Details of the Drug

General Information of Drug (ID: DM7HRLQ)

Drug Name

212Pb-TCMC-trastuzumab

Synonyms

Lead212-labeled trastuzumab (cancer), AREVA/NCI; Radioimmunotherapeutic-212Pb (cancer), AREVA/NCI; Radioimmunotherapeutic-lead212 (cancer), AREVA/NCI

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Monoclonal antibody

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01384253) Safety Study of b-TCMC-Trastuzumab Radio Immunotherapy. U.S. National Institutes of Health.